0
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
upcomingNational Institutes of Health
No deadline
Why this scored 0
Medical research (cancer assay validation); clinical/laboratory focus, not infrastructure or IT.
Overview
PAR-26-091 · forecast · CFDA 93.394
Client matchesAI suggests · you decide
No client matches yet. Run matching to see which of PCC2K's clients could apply for this grant.